205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.07%
Revenue growth at 50-75% of LSCC's 7.49%. Martin Whitman would worry about competitiveness or product relevance.
6.28%
Gross profit growth at 50-75% of LSCC's 9.97%. Martin Whitman would question if cost structure or brand is lagging.
8.28%
EBIT growth 75-90% of LSCC's 10.44%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
8.59%
Operating income growth at 75-90% of LSCC's 10.44%. Bill Ackman would demand a plan to enhance operating leverage.
9.81%
Net income growth 1.25-1.5x LSCC's 6.71%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
9.48%
EPS growth above 1.5x LSCC's 5.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
9.66%
Diluted EPS growth above 1.5x LSCC's 5.26%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.11%
Share reduction more than 1.5x LSCC's 0.30%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
12.62%
Dividend growth of 12.62% while LSCC is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-2.92%
Negative OCF growth while LSCC is at 13.89%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-44.64%
Negative FCF growth while LSCC is at 14.74%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
73.70%
Similar 10Y revenue/share CAGR to LSCC's 73.29%. Walter Schloss might see both firms benefiting from the same long-term demand.
52.56%
5Y revenue/share CAGR above 1.5x LSCC's 1.40%. David Dodd would look for consistent product or market expansions fueling outperformance.
34.08%
3Y revenue/share CAGR at 75-90% of LSCC's 39.62%. Bill Ackman would expect new product strategies to close the gap.
198.43%
10Y OCF/share CAGR 1.25-1.5x LSCC's 145.34%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
83.17%
5Y OCF/share CAGR at 75-90% of LSCC's 94.65%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
13.33%
3Y OCF/share CAGR under 50% of LSCC's 58.01%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
782.06%
Positive 10Y CAGR while LSCC is negative. John Neff might see a substantial advantage in bottom-line trajectory.
120.11%
Below 50% of LSCC's 395.18%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
77.97%
Below 50% of LSCC's 478.67%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
49.67%
Positive growth while LSCC is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
37.23%
5Y equity/share CAGR 1.25-1.5x LSCC's 28.56%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
52.90%
3Y equity/share CAGR similar to LSCC's 50.52%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
576.51%
Dividend/share CAGR of 576.51% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
129.41%
Dividend/share CAGR of 129.41% while LSCC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
48.82%
3Y dividend/share CAGR of 48.82% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
2.90%
AR growth well above LSCC's 0.32%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.52%
Inventory growth well above LSCC's 2.25%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.03%
Asset growth above 1.5x LSCC's 3.07%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
9.61%
BV/share growth above 1.5x LSCC's 4.45%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
6.03%
We have some new debt while LSCC reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.26%
R&D dropping or stable vs. LSCC's 5.07%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-1.94%
We cut SG&A while LSCC invests at 9.04%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.